VACCITECH (SP.ADR)/1 Cash Flow Conversion Efficiency

Latest as of March 2026: -0.051x

VACCITECH (SP.ADR)/1 cash flow conversion efficiency. Based on the latest financial reports, VACCITECH (SP.ADR)/1 (2AB) has a cash flow conversion efficiency ratio of -0.051x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.37 Million ≈ $-3.94 Million USD) by net assets (€66.48 Million ≈ $77.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of VACCITECH (SP.ADR)/1 (2021–2025)

Cash flow conversion efficiency of VACCITECH (SP.ADR)/1 from 2021 to 2025. This chart illustrates how VACCITECH (SP.ADR)/1's cash flow conversion efficiency has evolved over time, based on yearly financial data. View VACCITECH (SP.ADR)/1 share price for real-time trading data and today's change.

VACCITECH (SP.ADR)/1 Cash Flow Conversion Ratio Explained

VACCITECH (SP.ADR)/1 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

VACCITECH (SP.ADR)/1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of VACCITECH (SP.ADR)/1 ranked by their cash flow conversion efficiency. Also see VACCITECH (SP.ADR)/1 (2AB) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Tek-Art Insaat Ticaret Turizm Sanayi ve Yatirimlar AS IS:TEKTU	0.000x
Pure Hydrogen Corporation Ltd AU:PH2	-0.252x
Fu Burg Industrial Co Ltd TWO:8929	-0.044x
Rex Industry Bhd KLSE:9946	-0.051x
Bangsaphan Barmill Public Company Limited BK:BSBM	-0.040x
Korean Drug Co. Ltd KQ:014570	0.024x
HiTi Digital Inc TW:3494	0.088x
Zuleika Gold Ltd AU:ZAG	0.144x

Annual Cash Flow Conversion Efficiency for VACCITECH (SP.ADR)/1 (2021–2025)

The table below shows the annual cash flow conversion efficiency of VACCITECH (SP.ADR)/1 from 2021 to 2025. Review VACCITECH (SP.ADR)/1 (2AB) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€74.29 Million ≈ $86.86 Million	€-47.98 Million ≈ $-56.09 Million	-0.646x	-190.41%
2024-12-31	€130.13 Million ≈ $152.14 Million	€-28.94 Million ≈ $-33.83 Million	-0.222x	+18.34%
2023-12-31	€187.00 Million ≈ $218.62 Million	€-50.92 Million ≈ $-59.54 Million	-0.272x	-358.95%
2022-12-31	€243.20 Million ≈ $284.33 Million	€-14.43 Million ≈ $-16.87 Million	-0.059x	+54.01%
2021-12-31	€252.56 Million ≈ $295.27 Million	€-32.58 Million ≈ $-38.09 Million	-0.129x	--

About VACCITECH (SP.ADR)/1

F:2AB Germany Biotechnology

Market Cap

$24.11 Million

€20.62 Million EUR

Market Cap Rank

#24866 Global

#2142 in Germany

Share Price

€0.51

Change (1 day)

+5.65%

52-Week Range

€0.45 - €1.54

All Time High

€14.00